These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37680888)

  • 1. The role of lactoferrin in bone remodeling: evaluation of its potential in targeted delivery and treatment of metabolic bone diseases and orthopedic conditions.
    Tian M; Han YB; Yang GY; Li JL; Shi CS; Tian D
    Front Endocrinol (Lausanne); 2023; 14():1218148. PubMed ID: 37680888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin stimulates osteoblast differentiation through PKA and p38 pathways independent of lactoferrin's receptor LRP1.
    Zhang W; Guo H; Jing H; Li Y; Wang X; Zhang H; Jiang L; Ren F
    J Bone Miner Res; 2014; 29(5):1232-43. PubMed ID: 24877241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of TGF-β Canonical and Noncanonical Signaling in Bovine Lactoferrin-Induced Osteogenic Activity of C3H10T1/2 Mesenchymal Stem Cells.
    Li Y; Zhang W; Ren F; Guo H
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin induces tropoelastin expression by activating the lipoprotein receptor-related protein 1-mediated phosphatidylinositol 3-kinase/Akt pathway in human dermal fibroblasts.
    Ryu M; Nogami A; Kitakaze T; Harada N; Suzuki YA; Yamaji R
    Cell Biol Int; 2017 Dec; 41(12):1325-1334. PubMed ID: 28833753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin Promotes Osteogenesis through TGF-β Receptor II Binding in Osteoblasts and Activation of Canonical TGF-β Signaling in MC3T3-E1 Cells and C57BL/6J Mice.
    Li Y; Wang J; Ren F; Zhang W; Zhang H; Zhao L; Zhang M; Cui W; Wang X; Guo H
    J Nutr; 2018 Aug; 148(8):1285-1292. PubMed ID: 29931165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine lactoferrin enhances osteogenesis through Smad2/3 and p38 MAPK activation.
    Inubushi T; Kosai A; Yanagisawa S; Chanbora C; Miyauchi M; Yamasaki S; Sugiyama E; Ishikado A; Makino T; Takata T
    J Oral Biosci; 2020 Jun; 62(2):147-154. PubMed ID: 32464258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
    Zhu Y; Culmsee C; Klumpp S; Krieglstein J
    Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin Mediates Enhanced Osteogenesis of Adipose-Derived Stem Cells: Innovative Molecular and Cellular Therapy for Bone Repair.
    Chang Y; Ping A; Chang C; Betz VM; Cai L; Ren B
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin in Bone Tissue Regeneration.
    Icriverzi M; Dinca V; Moisei M; Evans RW; Trif M; Roseanu A
    Curr Med Chem; 2020; 27(6):838-853. PubMed ID: 31258057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
    Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
    Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling.
    Golden D; Saria EA; Hansen MF
    J Cell Physiol; 2015 Dec; 230(12):2951-60. PubMed ID: 25893522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.
    Chatterton DE; Nguyen DN; Bering SB; Sangild PT
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosavin suppresses osteoclastogenesis
    Zhang W; Zhang W; Huo L; Chai Y; Liu Z; Ren Z; Yu C
    Ann Transl Med; 2021 Mar; 9(5):383. PubMed ID: 33842604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: Impact of the p-Akt/PTEN pathway.
    Mohamed WA; Salama RM; Schaalan MF
    Biomed Pharmacother; 2019 Mar; 111():714-723. PubMed ID: 30611996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anethole inhibits RANKL-induced osteoclastogenesis by downregulating ERK/AKT signaling and prevents ovariectomy-induced bone loss in vivo.
    Qu H; Zhang Y; He R; Lin N; Wang C
    Int Immunopharmacol; 2021 Nov; 100():108113. PubMed ID: 34530203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.